192
A. Agac et al. / Journal of Organometallic Chemistry 819 (2016) 189e193
4. Experimental
found 326.1657.
4.1. General remarks
4.1.3. Preparation of ruthenium complex 6e
i
Ru(PPh3)dppbCl2 (1.1 g, 1.27 mmol) was suspended in PrOH
(6 mL) and (S)-2-phenyl-1-(4-phenylquinazolin-2-yl)ethan-1-
amine 3e (0.5 g, 1.5 mmol) and Et3N (1.3 g, 12.9 mmol) were added.
The resulting mixture was then refluxed for 6 h at nitrogen atmo-
sphere. The precipitate was filtered and washed petroleum ether
(20 mL) and diethyl ether (2 ꢂ 20 mL). The ruthenium complex 6e
was obtained as an orange solid (0.78 g, 67%). mp: 224e226 ꢁC; IR
(KBr, cm-1) 3457, 3027, 2970, 1738, 1564, 1526, 1431, 1365, 696, 515,
Reagents and solvents were purchased from chemical suppliers
and purified to match the reported physical and spectroscopic data.
The solvents were carefully dried using standard methods. Melting
points were determined with an Electro thermal IA9100 apparatus.
IR spectra were obtained on KBr pellets with a Perkin Elmer
apparatus. 1H and 13C NMR spectra were recorded on Bruker
(300 MHz, 400 MHz and 600 MHz) spectrometers in CDCl3. The
conversions and enantioselectivity ratios were determined by GC
analysis with YL6500 Instrument and by HPLC analysis with Hitachi
7000 series. All column chromatography was performed on silica
gel (230e400mesh).
505.; 1H NMR (600 MHz, CDCl3)
d
10.50 (d, J ¼ 8.7 Hz, 1H), 8.41 (t,
J ¼ 8.6 Hz, 2H), 8.03 (t, J ¼ 7.6 Hz, 1H), 7.87e6.87 (m, 30H), 6.76 (d,
J ¼ 7.0 Hz, 2H), 6.45 (t, J ¼ 6.8 Hz, 2H), 4.21 (t, J ¼ 13.3 Hz, 1H),
4.11e3.82 (m, 3H), 3.69 (t, J ¼ 11.9 Hz, 1H), 2.90 (d, J ¼ 13.2 Hz, 1H),
2.76e2.25 (m, 3H), 2.14e1.78 (m, 2H); 31P NMR (121 MHz, CDCl3)
4.1.1. Synthesis of t-butyl (S)-(2-phenyl-1-(4-phenylquinazolin-2-
yl)ethyl)carbamate 5e
d
54.40 (d, J ¼ 39.2 Hz), 52.68 (d, J ¼ 39.2 Hz), 41.54 (d, J ¼ 39.0 Hz),
39.89 (d, J ¼ 39.0 Hz); HRMS (ESI) m/z calc. for C52H50ClN4P2Ru
[MꢀCl CH3CN] 929.2243, found 929.2248; Anal. calc. for
50H47Cl2N3P2Ru (%): C, 65.00; H, 5.13; Cl, 7.67; N, 4.55; found: C,
t-butyl
(S)-(1-(4-chloroquinazolin-2-yl)-2-phenylethyl)carba-
þ
mate 4e (5.1 g, 13,28 mmol), phenylboronic acid (2.73 g,
22.39 mmol), Pd(PPh3)4 (307 mg, 026 mmol) and Na2CO3 (29 mL,
1 M in water) were dissolved in dimethoxyethane (45 mL) and
ethanol (45 mL) and the resulting mixture was then refluxed for 4 h.
The solution was cooled to ambient temperature, after the addition
of water (100 mL), the organic material was extracted with ethyl
acetate (3 ꢂ 100 mL). The combined organic layers were dried over
Na2SO4, and concentrated under reduced pressure. The crude
product was purified by column chromatography (silica gel, hexane/
EtOAc, 6:1) to give t-butyl (S)-(2-phenyl-1-(4-phenylquinazolin-2-
C
64.29, H, 5.23, N, 4.35.
4.1.4. General procedure for the asymmetric transfer hydrogenation
reaction
Ruthenium complex (3.7 mg, 0.004 mmol), ketone (2 mmol) and
NaOiPr (0.4 mL, 0.1 M) were dissolved in degassed PrOH (10 mL)
i
and the mixture was stirred under nitrogen atmosphere at appro-
priate temperature. A small volume of sample was taken from re-
action mixture and diluted with diethyl ether (1:1), and rapidly
filtered using a short silica pad. The conversion and enantiomeric
excess were determined by GC using Agilent HP-Chiral 20B column
yl)ethyl)carbamate 5e as
a
colourless oil (4.64 g, 82%).
½aꢃ2D0 ꢀ 45 (c ¼ 1.6 CHCl3); ee: 99.9%; retention time 9.7 min, Chir-
alcel OD-H, 95:5 n-hexane-iPrOH, flow rate of 0.5 mL/min, 254 nm;
IR (KBr, cmꢀ1) 3423, 2925, 2856, 1710, 1610, 1557, 1492, 1385, 1248,
(30 m, 0.25 mm, 0.25
chiral columns.
mm) and by HPLC using Supelco AD-H, OD-H
1168, 1054, 1025, 774, 700; 1H NMR (600 MHz, CDCl3, ppm)
d 8.02
(1H, d, J ¼ 8.2 Hz), 7.96 (1H, d, J ¼ 8.0 Hz), 7.80 (1H, t, J ¼ 7.3 Hz), 7.63
(2H, dd, J ¼ 6.5, 2.8 Hz), 7.56e7.46 (4H, m), 7.07 (4H, bs), 6.92 (1H,
bs), 5.91 (1H, d, J ¼ 6.7 Hz), 5.38 (1H, d, J ¼ 6.7 CHCH2PhHz), 3.41
(1H, dd, J ¼ 13.4, 5.9 Hz, CH2Ph), 3.29 (1H, dd, J ¼ 13.4, 5.9 Hz,
Acknowledgment
This presented study was supported by The Scientific and
Technological Research Council of Turkey (TUBITAK) (project
number is 112T816). We thank David N. Primer (University of
Pennsylvania) for proof reading.
CH2Ph), 1.38 (9H, s); 13C NMR (151 MHz, DMSO, ppm))
d 168.4,165.9,
156.0, 151.1, 138.9, 137.1, 134.8, 130.6, 130.4, 129.7, 129.0, 128.6, 128.5,
128.3, 127.2, 126.6, 121.4, 78.4, 59.1, 28.6, 28.2; HRMS (ESI) m/z calc.
for C27H28N3O2 [MþH] 426,2182, found 426.2179.
Appendix A. Supplementary data
4.1.2. Synthesis of (S)-2-phenyl-1-(4-phenylquinazolin-2-yl)ethan-
1-amine 3e
Supplementary data related to this article can be found at http://
t-butyl (S)-(2-phenyl-1-(4-phenylquinazolin-2-yl)ethyl)carba-
mate 5e (3.98 g, 9.35 mmol) was dissolved in CH2Cl2 (100 mL) and
triflouroacetic acid (10.64 g, 93.35 mmol) was added slowly at 0 ꢁC.
After stirring 24 h at room temperature, the reaction was quenched
with saturated NaHCO3 (100 mL) and extracted with CH2Cl2
(2 ꢂ 100 mL). The combined organic layers were dried over Na2SO4,
and concentrated under reduced pressure. The crude product was
purified by column chromatography (silica gel, CH2Cl2/methanol,
12:1) to give (S)-2-phenyl-1-(4-phenylquinazolin-2-yl)ethan-1-
amine 3e as a colourless oil (2.99 g, 98%). ½aꢃ2D0 þ 20 (c ¼ 0.7,
EtOH); ee: 99%; retention time 6.3 min, Chiralcel AD-H, 90:10 n-
hexane-iPrOH, flow rate of 1 mL/min, 254 nm; IR (KBr, cmꢀ1) 3455,
3009, 2970, 1738, 1435, 1365; 1H NMR (600 MHz, CDCl3, ppm)
References
d
8.00 (2H, t, J ¼ 9.2 Hz), 7.80 (1H, ddd, J ¼ 8.4, 6.9,1.1 Hz), 7.70e7.66
(2H, m), 7.51e7.46 (4H, m), 7.21e7.16 (4H, m), 7.14e7.10 (1H, m),
4.54 (1H, dd, J ¼ 8.8, 5.0 Hz,CHCH2Ph), 3.41 (1H, dd, J ¼ 13.6, 5.0 Hz,
CHCH2Ph), 2.99 (1H, dd, J ¼ 13.6, 8.8 Hz, CHCH2Ph), 2.51 (2H, bs,
NH2); 13C NMR (151 MHz, CDCl3, ppm)
d 166.6, 165.5, 149.3, 136.8,
135.4,131.7,128.1,128.0,127.6,126.7,126.6,126.4,125.2,125.1,124.4,
119.7, 57.4, 42.1; HRMS (ESI) m/z calc. for C22H20N3 [MþH] 326.1656,